Automated description from the Alliance of Genome Resources
Predicted to have cGMP binding activity and cGMP-stimulated cyclic-nucleotide phosphodiesterase activity. Predicted to be involved in negative regulation of cAMP-mediated signaling and negative regulation of cGMP-mediated signaling. Predicted to localize to the perikaryon. Human ortholog(s) of this gene implicated in primary pigmented nodular adrenocortical disease. Is expressed in axial skeleton and nervous system. Orthologous to human PDE11A (phosphodiesterase 11A).